Jointown Aesthetics ValleyCo.,Ltd. Class A (000615.SZ)
Xiangyang, CN
Jointown Aesthetics Valley Co., Ltd. is a provider of crucial technologies, specialized materials, and diverse services for the global beauty and health industries, with operations spanning both China and international markets. The company's business is structured across three main divisions: Chemical Fiber, Medical Beauty, and Warehousing. Its product offerings include the manufacture and sale of items such as lyocell fiber, viscose filament, glassine, chemical fiber pulp, and refined cotton. Furthermore, the company extends its services to include property administration and storage solutions. Originally founded in 1993, the firm's corporate identity was updated in February 2026, when it changed its name from Aoyuan Beauty Valley Technology Co.,Ltd. to its current designation, Jointown Aesthetics Valley Co., Ltd. Its primary administrative center is situated in Guangzhou, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.05% | +8.62% | +12.50% | +16.31% | +55.56% | +8.31% | +111.17% | +170.00% | -77.05% | -14.48% | +204.84% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-10.9% Q1'26: -37.7% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-38.1% Q1'26: -144.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-35.7% Q1'26: +1.1% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-38.0% Q1'26: -138.9% (vs Q1'25)
-
ROIC Chemicals: +3.4%-17.9% Q1'26: -56.6% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-8.5% ★ Q1'26: +114.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×-1.33× Q1'26: -0.34× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|---|---|---|
| Revenue |
3.15B
est: 3.18B (-0.8%)
|
1.99B
est: 1.99B (+0.0%)
|
2.01B
est.
|
1.59B
est: 1.40B (+13.9%)
|
1.36B
est: 1.60B (-15.2%)
|
1.36B
est: 1.60B (-14.7%)
|
1.09B
est: 1.79B (-38.8%)
|
| EBITDA |
411.96M
est: -786.01M (+152.4%)
|
390.74M
est: -491.57M (+179.5%)
|
-497.47M
est.
|
-21.87M
est: -345.09M (+93.7%)
|
-1.36B
est: -395.55M (-243.8%)
|
-212.99M
est: -395.55M (+46.2%)
|
-199.40M
est: -574.85M (+65.3%)
|
| EBIT |
404.27M
est: -998.74M (+140.5%)
|
317.17M
est: -624.61M (+150.8%)
|
-632.11M
est.
|
-109.86M
est: -438.49M (+74.9%)
|
-1.47B
est: -502.61M (-192.0%)
|
-329.06M
est: -502.61M (+34.5%)
|
-300.89M
est: -702.82M (+57.2%)
|
| Net Income |
12.09M
est: 174.86M (-93.1%)
|
-134.75M
est: -140.65M (+4.2%)
|
258.49M
est.
|
-283.78M
est: 121.64M (-333.3%)
|
-1.61B
est: 152.05M (-1,157.5%)
|
-376.11M
est: 152.05M (-347.4%)
|
-349.72M
est: 191.30M (-282.8%)
|
| SGA |
492.28M
est: 595.95M (-17.4%)
|
283.88M
est: 372.71M (-23.8%)
|
377.18M
est.
|
441.19M
est: 261.64M (+68.6%)
|
325.42M
est: 299.91M (+8.5%)
|
321.31M
est: 299.91M (+7.1%)
|
261.50M
est: 396.46M (-34.0%)
|
| EPS |
0.02
est: 0.23 (-92.1%)
|
-0.15
est: -0.19 (+18.9%)
|
0.34
est.
|
-0.33
est: 0.16 (-306.3%)
|
-1.92
est: 0.20 (-1,060.0%)
|
-0.45
est: 0.20 (-325.0%)
|
-0.42
est: 0.25 (-268.0%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-26 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-19 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jianwei Zhang | Secretary of the Board of Directors & Director | — | male |
| Shijie Fan | President & Employee Director | — | male |
| Song Yun | Vice President | — | male |
| Yongbiao Jiang | Chief Financial Officer, Accounting Supervisor & Non-Independent Director | — | male |
| Zhen Zhang | Vice President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 000615.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
